Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 31/3/19941 min de lectura
Solvay Pharmaceuticals et al.; Withdrawal of Approval of 24 Abbreviated New Drug Applications
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is withdrawing approval of 24 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Idioma original de la fuente: Federal Register — Health and Human ServicesAbrir el comunicado original →